We are live on ! Find out more
PBMWW

Psyence Biomedical Warrant
PBMWW

23 hedge funds and large institutions have $124K invested in Psyence Biomedical Warrant in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

34.26% more ownership

Funds ownership: 12.57% → 46.83% (+34%)

28% more capital invested

Capital invested by funds: $96.4K → $124K (+$27.3K)

0% more funds holding

Funds holding: 23 → 23 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
3
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$8.05K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.86K
3
PA
Parallel Advisors
California
+$800
4
SIA
SkyView Investment Advisors
New Jersey
+$280

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$3.38K
2
VF
Virtu Financial
New York
-$1K
3
UBS Group
UBS Group
Switzerland
-$27

PBMWW Hedge Fund Activity: Q2 2025 in Review

23 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q2 2025, worth a combined $124K — up 28% from $96.4K a quarter earlier.

Fund positioning in PBMWW was balanced in Q2 2025: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $8.05K. The largest seller was Periscope Capital, exiting entirely with an estimated $3.38K sold.

  • 23 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $124K of Psyence Biomedical Warrant stock for Q2 2025, up 28% quarter-over-quarter.
  • 3 funds opened new Psyence Biomedical Warrant positions in Q2 2025 and 3 closed out, a net change of 0 holders.
  • The largest Psyence Biomedical Warrant buyer in Q2 2025 was Toronto Dominion Bank, an estimated $8.05K added.
  • The largest Psyence Biomedical Warrant seller in Q2 2025 was Periscope Capital, an estimated $3.38K sold.

Based on aggregated 13F filings for Q2 2025.